Nexalin Technology, Inc. (NASDAQ:NXL) CFO Purchases $10,640.00 in Stock
Nexalin Technology, Inc. (NASDAQ:NXL) CFO Purchases $10,640.00 in Stock
$Nexalin Technology (NXL.US)$ CFO Marilyn Elson purchased 9,500 shares of the firm's stock in a transaction that occurred on Wednesday, September 28th. The stock was purchased at an average price of $1.12 per share, with a total value of $10,640.00. Following the purchase, the chief financial officer now directly owns 835,244 shares of the company's stock, valued at $935,473.28. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink.
About Nexalin Technology
Nexalin Technology, Inc, a medical device company, designs and develops neurostimulation products for the treatment of mental health in the United States and China. It licenses and markets Nexalin Device, a non-invasive and drug-free therapy for the treatment of anxiety and insomnia. The company's Nexalin device emits a patented frequency-based waveform, which stimulates a positive response from the mid-brain structures associated with various mental health disorders.
$Nexalin Technology (NXL.US)$ CFO Marilyn Elson purchased 9,500 shares of the firm's stock in a transaction that occurred on Wednesday, September 28th. The stock was purchased at an average price of $1.12 per share, with a total value of $10,640.00. Following the purchase, the chief financial officer now directly owns 835,244 shares of the company's stock, valued at $935,473.28. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink.
$Nexalin Technology (NXL.US)$首席財務官瑪麗蓮·埃爾森在9月28日星期三進行的一筆交易中購買了該公司9,500股股票。該股票的平均購買價格爲每股1.12美元，總價值爲10,640.00美元。收購後，首席財務官現在直接擁有該公司835,244股股票，價值935,473.28美元。該交易已在向美國證券交易委員會提交的法律文件中披露，該文件可通過以下方式獲得 這個超鏈接。
About Nexalin Technology
關於 Nexalin 科技
Nexalin Technology, Inc, a medical device company, designs and develops neurostimulation products for the treatment of mental health in the United States and China. It licenses and markets Nexalin Device, a non-invasive and drug-free therapy for the treatment of anxiety and insomnia. The company's Nexalin device emits a patented frequency-based waveform, which stimulates a positive response from the mid-brain structures associated with various mental health disorders.
醫療器械公司Nexalin Technology, Inc在美國和中國設計和開發用於治療心理健康的神經刺激產品。它許可和銷售Nexalin Device，這是一種用於治療焦慮和失眠的非侵入性和無藥物療法。該公司的Nexalin設備發出一種獲得專利的基於頻率的波形，該波形可刺激與各種心理健康障礙相關的中腦結構的積極反應。
譯文內容由第三人軟體翻譯。
風險及免責聲明
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用瀏覽器的分享功能，分享給你的好友吧